Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Transl Radiat Oncol ; 21: 1-4, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-31867448

RESUMO

•The optimal treatment of primary cutaneous angiosarcoma is considered to be surgical exision.•Concurrent chemo-radiotherapy is efficient in the treatment of primary cutaneous angiosarcoma.•The toxicity profile of this association is acceptable.

2.
Cancer Radiother ; 5(6): 737-42, 2001 Dec.
Artigo em Francês | MEDLINE | ID: mdl-11797294

RESUMO

PURPOSE: Iodine 125 curietherapy is one of the conservative treatments of uveal melanoma. The technique used to achieve these results was simplified through the physical characteristics of the radioelement and the optimized-dosimetry program employed. PATIENTS AND METHODS: 78 patients with choroidal melanoma were treated with iodine 125. About 100 Gy were delivered to the superior pole of the tumour. The minimal length of follow-up was 17 months and the average, 67 months. RESULTS: There was 88% local control, leading to lowered visual acuity in 76% of the cases. Radiation retinopathy, directly related to proximity to the macula, is the principle etiology. Seven patients died of hepatic metastasis, five patients were enucleated. Four patients were further treated with protontherapy to make up for noncontrol locally. CONCLUSION: One dose of 100 Gy to the superior pole of the tumor seemed to lead to good local control, with the exception of complications related to proximity to the macula and the optic nerve. In this attempt to optimize irradiation, the time lapse between any benefit in local control derived from irradiation and posttherapeutic complications observed remains insufficient to evaluate any relationship.


Assuntos
Braquiterapia/métodos , Melanoma/radioterapia , Neoplasias Uveais/radioterapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Braquiterapia/efeitos adversos , Enucleação Ocular , Feminino , Humanos , Radioisótopos do Iodo , Neoplasias Hepáticas/secundário , Masculino , Melanoma/patologia , Pessoa de Meia-Idade , Doenças Retinianas/etiologia , Estudos Retrospectivos , Resultado do Tratamento , Neoplasias Uveais/patologia
3.
Br J Cancer ; 83(5): 642-9, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10944606

RESUMO

Caspases, a family of cysteine proteases, play a central role in the pathways leading to apoptosis. Recently, it has been reported that a broad spectrum inhibitor of caspases, the tripeptide Z-VAD-fmk, induced a switch from apoptosis to necrosis in dexamethasone-treated B lymphocytes and thymocytes. As such a cell death conversion could increase the efficiency of radiation therapy and in order to identify the caspases involved in this cell death transition, we investigated the effects of caspase-3-related proteases inhibition in irradiated MOLT-4 cells. Cells were pretreated with Ac-DEVD-CHO, an inhibitor of caspase-3-like activity, and submitted to X-rays at doses ranging from 1 to 4 Gy. Our results show that the inhibition of caspase-3-like activity prevents completely the appearance of the classical hallmarks of apoptosis such as internucleosomal DNA fragmentation or hypodiploid particles formation and partially the externalization of phosphatidylserine. However, this was not accompanied by any persistent increase in cell survival. Instead, irradiated cells treated by this inhibitor exhibited characteristics of a necrotic cell death. Therefore, functional caspase-3-subfamily not only appears as key proteases in the execution of the apoptotic process, but their activity may also influence the type of cell death following an exposure to ionizing radiation.


Assuntos
Caspases/metabolismo , Morte Celular/efeitos da radiação , Leucemia/patologia , Leucemia/radioterapia , Oxazinas , Xantenos , Anexina A5/farmacologia , Apoptose , Western Blotting , Caspase 3 , Caspase 7 , Catálise , Sobrevivência Celular/efeitos da radiação , Corantes/farmacologia , Inibidores de Cisteína Proteinase/farmacologia , Fragmentação do DNA , Relação Dose-Resposta à Radiação , Inibidores Enzimáticos/farmacologia , Citometria de Fluxo , Fluoresceína-5-Isotiocianato/farmacologia , Corantes Fluorescentes/farmacologia , Humanos , Marcação In Situ das Extremidades Cortadas , L-Lactato Desidrogenase/metabolismo , Necrose , Oligopeptídeos/farmacologia , Fosfatidilserinas/metabolismo , Propídio/farmacologia , Radiação Ionizante , Fatores de Tempo , Células Tumorais Cultivadas , Raios X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA